Zhenhai Gao is the founder of NiKang Therapeutics. NiKang Therapeutics has raised $250M in total funding. Latest round: Series C. Backed by CBC Group.
Zhenhai Gao, Ph.D., is the Co-Founder, President, and CEO of NiKang Therapeutics, a clinical-stage biotechnology company focused on developing innovative cancer treatments. He founded the company in 2017, following incubation by the Chinese venture capital firm CBC Group, and leads its strategic direction.
Full founder directory · Investor directory · Company funding database · Fundraising library